Menu
Back to Journals » Journal of Inflammation Research » Anti-inflammatory Biologics – A Game Changer for Chronic Inflammation
SJR OA
CiteScore
Impact Factor
ISSN: 1178-7031
- View all (3212)
- Volume 18, 2025 (567)
- Volume 17, 2024 (804)
- Volume 16, 2023 (460)
- Volume 15, 2022 (493)
- Volume 14, 2021 (541)
- Volume 13, 2020 (112)
- Volume 12, 2019 (35)
- Volume 11, 2018 (47)
- Volume 10, 2017 (20)
- Volume 9, 2016 (24)
- Volume 8, 2015 (21)
- Volume 7, 2014 (17)
- Volume 6, 2013 (14)
- Volume 5, 2012 (17)
- Volume 4, 2011 (13)
- Volume 3, 2010 (15)
- Volume 2, 2009 (6)
- Volume 1, 2008 (6)
Journal Articles:
- Takayasu Arteritis: Insights Into Pathogenesis, Disease Assessment, Treatment, and Outcomes (2)
- Inflammation and brain: how inflammatory processes influence physiological and pathological functions of the central nervous system (12)
- Genetic and non-genetic inflammation networks in major human diseases (6)
- Neurodegenerative diseases: From Pathogenesis to Treatment (1)
- Unraveling the Complex Relationship Between Inflammation, Diabetes, and Obesity: A Comprehensive Exploration (2)
Anti-inflammatory Biologics – A Game Changer for Chronic Inflammation
Chronic inflammation is the hallmark of many diseases. These conditions can be crippling to patients. Traditional anti-inflammatory drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids, are non-specific, causing further systemic problems with continued use. By contrast, biologic therapies harness the specificity necessary to relieve inflammation while also reducing off-target and non-specific effects.